Preliminary clinical experience of PCSK9 inhibitors in patients with heterozygous familial hypercholesterolemia. Considerations on their use in patients on lipoprotein apheresis treatment and in statins intolerant patients

Autor:	V. Sanga, M. G. Zenti, Anna Altomari, A. Lupo, Marco Dauriz, Enzo Bonora, A. Fabris, G. Ceradini
Rok vydání:	2017
Předmět:	medicine.medical_specialty Nutrition and Dietetics business.industry Endocrinology Diabetes and Metabolism Medicine (miscellaneous) Familial hypercholesterolemia medicine.disease Internal medicine medicine In patient Cardiology and Cardiovascular Medicine PCSK9 Inhibitors business Lipoprotein apheresis
Zdroj:	Nutrition, Metabolism and Cardiovascular Diseases. 27:e4-e5
ISSN:	0939-4753
DOI:	10.1016/j.numecd.2016.11.012
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::30394b6ea2e03bb6037b2ca844c4b717 https://doi.org/10.1016/j.numecd.2016.11.012 Zobrazit plný text záznamu Full Text from ScienceDirect